title: Advancements in Topical Antifungal Vehicles.
abstract: The primary treatment for superficial fungal infections is antifungal topical formulations, and allylamines and azoles represent the two major classes of topical formulations that are used to treat these infections. The stratum corneum (SC) is composed of keratinocytes that are surrounded by a matrix of lipids. The efficacy of topically applied formulations depends on their ability to penetrate this lipid matrix, and the vehicle plays an integral role in the penetration of active molecule into skin. There are several challenges to formulating topical drugs, which include the biotransformation of the active molecules as they pass through the SC and the physical changes that occur to the vehicle itself when it is applied to the skin. This article will review current and emerging topical antifungal vehicles.
authors.forename: Leon H
authors.initials: LH
authors.lastname: Kircik
mesh_terms: D000279:Administration, Cutaneous; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D003881:Dermatomycoses / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D004337:Drug Carriers / Q000008:administration & dosage* / Q000493:pharmacokinetics; D004817:Epidermis / Q000187:drug effects* / Q000378:metabolism / Q000382:microbiology; D006801:Humans
chemical_list: D000935:Antifungal Agents; D003879:Dermatologic Agents; D004337:Drug Carriers